Grants

Active grants by sponsorship and scheme

• Hungarian
• EU Framework Programme (FP)

Completed grants by sponsorship and scheme

• Hungarian
• EU Framework Programme (FP)

Active grants by sponsorship and scheme
HUNGARIAN

National Office for Research and Technology

National Technology Programme - 2008/1
Development of in vitro diagnostic test systems for predicting drug-resistance (IVDMDQ08)
Coordinator: SOLVO Biotechonology
Partners: University of Debrecen, Medical and Health Science Center; University of Pécs, Medical School; University of Szeged, Albert Szent-Györgyi Clinical Center; 77 Elektronika Ltd; T-Cell Technologies Ltd., Laboratory of Tumor Pathology and Molecular Diagnostics

Oszkár Asbóth Programme - Focus Sector Innovation Program (FSIP) - 2005
Xenobiotic Transporter Technology Platform (XTTP) - Therapeutical and Toxicological Applications (XTTPSRT1)
Coordinator: SOLVO Biotechonology
Partners: University of Szeged; Biological Research Center of the Hungarian Academy of Science; Agricultural Biotechnological Research Centre; LAB Research International Hungary Ltd.; Avidin Ltd.

Péter Pázmány Programme
Leading edge technologies in the Debrecen University Region: applications in genomics, nano- and biotechnologies (RET-06/2004)
Coordinator: University of Debrecen
Partners: National Instruments Europe Ltd.; Metalelektro Ltd.; Szinapszis Ltd.; Labexpert Ltd.; ACROM; Kéri Pharma; Papp-Ker Ltd.Mastergood Ltd.; Bakonszeg AWASSI; Juhker Ltd.; North Great Plain Regional Agricultural Innovation and Technology Transfer Centre Non-profit Company; SANATMETAL Manufacturer of Orthopaedic and Traumatologic Products; Comgenex Research and Development Inc.; SOLVO Biotechnology; Experimetria Ltd.; Synonens Research and Development Ltd.

Ányos Jedlik Programme
Development of novel multi-target anti-inflammatory molecules using primary human phagocyte cellular assay systems (Inflamin)
Coordinator: Vichem Chemie Research Ltd.
Partners: Semmelweis University; Office for Academy Research Groups Attached to Universities, Peptide Biochemistry Research Group; SOLVO Biotechnology; University of Debrecen

László Kozma Programme
Development of HTS kit for analyzing transporter-drug interactions using cholesterol treated insect-cells expressing human MXR transporter.
Coordinator: SOLVO Biotechnology.
Partners: none

Active grants by sponsorship and scheme
EU FRAMEWORK PROGRAMME (FP)

Eustroke - European stroke research network
Call: FP7-HEALTH-2007-A
Instrument: CP-Large Scale Integration Project
Contract number: HEALTH-F2-2008-202213
Eustroke on Cordis

Biosimulation- A New Tool in Drug Development ("BioSim")
Call: FP6-2004-LIFESCIHEALTH
Instrument: NoE
Contract number: 005137, Co-PI
Biosim on Cordis

Membrane transporters: In vitro models for the study of their role in drug fate ("MEMTRANS")
Call: FP6-2004-LIFESCIHEALTH-5
Instrument: STREP
Contract number: 518246, Co-PI
Memtrans on Cordis

Non-viral gene transfer ("INTHER")
Call: FP6-2004-LIFESCIHEALTH-5
Instrument: STREP
Contract number: LSBH-CT-2005-018961 Co-PI
Inther on Cordis

European Network to Promote Research into Uncommon Cancers in Adults and Children: Pathology, Biology and Genetics of Bone Tumours ("EuroBoNet")
Call: FP6-2004-LIFESCIHEALTH-5
Instrument: NoE
Contract number: 018814, Participant
Eurobonet on Cordis

EC Optimisation of liver and intestine in vitro models for pharmacokinetics and pharmacodynamics studies ("LIINTOP")
Call: FP6-2005-LIFESCIHEALTH-6
Instrument: STREP
Contract number: LSBH-CT-2006-037499, Co-PI
Lintop on Cordis

Completed grants by sponsorship and scheme
HUNGARIAN

National Office for Research and Technology

Oszkár Asbóth Programme - Focus Sector Innovation Program (FSIP) - 2005
DermaVir - Vaccine therapy innovation technological cluster (DermaVir)
Coordinator: Chemical Research Center Hungarian Academy of Sciences
Partners: ERCOM Ltd.; GENETIC IMMUNITY Kft.; Semmelweis University, Institute of Pathophysiology; University of Szeged; SOLVO Biotechnology; L&MARK Kft.; St. Laszlo Hospital

Péter Pázmány Program
Neurobiological Knowledge Center - Therapeutic-Aimed neurobiological researches, from the molecule to the integrated functioning of the nervous systems (RET-08/2004)
Coordinator: University of Szeged
Partners: Biological Research Center of Szeged of the Hungarian Academy of Science; Hungarian Academy of Sciences Supported Research Groups; EGIS Pharmaceuticals; SOLVO Biotechnology; Diagnosticum Inc.; Kromat Ltd.; Creative Labor Ltd.; Rytmion R&D Ltd.; Kation Europe; QualiCont In Vitro Diagnostics; South-Plain Bioinnovation Center, Genomic Laboratory (DIABIC)

National Research and Development Programmes (NKFP)
Investigation of cyclodextrin-cell membrane interactions to develop "second generation" cyclodextrins more efficient in drug formulation (NKFP-1A/041/2004)
Coordinator: Cyclolab Research-Development Laboratory Ltd.
Partners: Solvo Biotechnology; University of Debrecen; HAS- Institute of Enzimology; University of Szeged, Department of Medical Chemistry

Development of molecular therapeutic tools for pharmacological modulation of the effects of Progesterone Induced Blocking Factor (NKFP-1A/057/2004)
Coordinator: Solvo Biotechnology
Partners: University of Pécs, Faculty of Medicine Dept. Of Microbiology and Immunology; Biological Research Center of the Hungarian Academy of Science, Institute of Chemistry; Intercell Biomedical Research and Development AG; Semmelweis University Cooperative Research Centre, Rational Drug Design Laboratory; University of Szeged, Department of Medical Chemistry; University of Szeged, Faculty of Pharmacy, Dept. Pharmacodynamics and Biopharmacy; KPS Biotechnology Ltd.; L&Mark Informatika

Development and application of cell- and gene-therapy methods in medicine (NKFP-1A/060/2004)
Coordinator: National Medical Center, Department of Hematology and Immunology
Partners: HungAcadSci Institute of Experimental Medicine; Semmelweis University, Department of Surgery and Transplantion, First Department of Pediatric; HungAcadSci SzBK Institute of Enzimology, Economy and Biotechnology Research Center; Diagnostikum Ltd.; Solvo Biotechnology; MikroVákuum Ltd

Economic Competitiveness Operative Programme (EU Co-financed)

Economic Competitiveness Operative Programme - 3.3.2- Development of Company Research Infrastructure
Development of a novel biopharmacological and diagnostic methods (GVOP-3.3.2.-2004-04-0001/3.0)
Coordinator: SOLVO Biotechnology

Economic Competitiveness Operative Programme - 3.1.1. - Applied Research & Development - 2004
Development of a new method based on PIBF measurement to diagnose malignant tumours and threatening abortion (GVOP-3.1.1.-2004-05-0329/3.0)
Coordinator: University of Pécs
Partners: SOLVO Biotechnology; Cooperative Research Center (SE)

In vitro pharmacokinetics; Development of high-through-put systems suitable for in vitro ADME-Tox investigations (vesicular-transport, ATP-ase and cellular model systems) (GVOP-3.1.1.-2004-05-0506/3.0)
Coordinator: SOLVO Biotechnology
Partners: HungAcadSci- Department of Enzimology, BRC

Development of cellular model systems expressing multidrug resistant proteins for the biological characterization of protein kinase inhibitors (GVOP-3.1.1.-2004-05-0467/3.0)
Coordinator: Semmelweis University (Budapest)
Partners: Cooperative Research Center (SE); National medical Center; Solvo Biotechnology; Vichem Chemie Ltd.

Development of in silico and in vitro methods for the prediction of multidrug resistance and penetration of blood-brain barrier (GVOP-3.1.1.-2004-05-0440/3.0)
Coordinator: ComGenex Ltd.
Partners: Solvo Biotechnology; University of Debrecen; ComGrid Ltd.

Multidrug Resistance Kit in rheumatoid arthritis (GVOP-3.1.1.-2004-05-0243/3.0)
Coordinator: Semmelweis University (Budapest)
Partners: County Hospital, Kecskemét; Solvo Biotechnology; Goodwill Research Ltd.

Economic Competitiveness Operative Programme - 3.2.2. - Cooperative Research Centers - 2004
Establishment of the Human Biotechnological Research and Educational Center (GVOP-3.2.2.-2004-07-0015/3.0)
Coordinator: National Medical Center
Partners: Department of Medical Chemistry, Institute of Pathobiochemical and Molecular Biology, Semmelweis University; Department of Organic Chemistry, Eötvös Lóránd University of Science; Institute of Enzimology, Hungarian Academy of Sciences; Cytobiology Laboratory, Institute of Experimental Medical Science Research, Hungarian Academy of Sciences; Diagnosticum Ltd.; Solvo Biotechnology; Institute of Isotopes Co., Ltd.; Creative Development Deposit Company; GENOMED Ltd.; Csertex Ltd.; TRIGON Ltd.

Economic Competitiveness Operative Programme - 3.3.3 "Funding Company Innovation"
Development of assay systems to study the interaction of test drugs with SLC uptake transporters (GVOP-3.3.3-05/1.-2005-05-0118/3.0)
Beneficiary: Solvo Biotechnology

Economic Competitiveness Operative Programme - 3.3.2 - Development of Company Research Infrastructure
Supporting research infrastructure for the development of assay systems to study the interaction of test drugs with SLC uptake transporters (GVOP-3.3.2-05/1.-2005-05-0015/3.0)
Beneficiary: Solvo Biotechnology

Completed grants by sponsorship and scheme
EU FRAMEWORK PROGRAMME (FP)